FDA Approves Additional Prefilled Syringe Size of Hizentra

The FDA has approved a new 50mL/10gm prefilled syringe for Hizentra (immune globulin subcutaneous [human] 20% liquid).

Related Keywords

United States ,America ,Bob Lojewski ,Drug Administration ,Senior Vice President ,General Manager ,North America ,